Henne Holstege

Citado por

	Total	Desde 2019
Citas	10370	7913
Índice h	41	32
Índice i10	75	71

3100

1550

775

2325

200320042005200620072008200920102011201220132014201520162017201820192020202120222023202432 38 68 44 74 102 138 183 175 202 198 164 218 248 243 277 275 402 687 1264 2157 3036

Acceso público

Ver todo

86 artículos

2 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Philip ScheltensProfessor of NeurologyDirección de correo verificada de amsterdamumc.nl
Jos JonkersProfessor at Leiden University and group leader at Netherlands Cancer Institute, Oncode InstituteDirección de correo verificada de nki.nl
Martijn HuismanDirección de correo verificada de vumc.nl
Sietske Sikkessenior researcher, VU University Medical CenterDirección de correo verificada de vumc.nl
Frederik BarkhofVU University Medical CenterDirección de correo verificada de vumc.nl
Lodewyk WesselsProfessor of Computational Cancer BiologyDirección de correo verificada de nki.nl
Pieter Jelle VisserMaastricht University and VU University Medical CentreDirección de correo verificada de vumc.nl
Petra M NederlofNetherlands Cancer Institute NKIDirección de correo verificada de nki.nl
Ylstra BaukeVU University Medical CenterDirección de correo verificada de vumc.nl
Frank StaalIHB, Molecular Stem Cell Biology LUMC, Universiteit LeidenDirección de correo verificada de lumc.nl
Lora K. HeislerRowett Institute of Nutrition and HealthDirección de correo verificada de abdn.ac.uk
Michael CowleyHead of Department and Professor of Medicine, Monash UniversityDirección de correo verificada de monash.edu
Patrick WB DerksenProfessor of Oncology @ UMC UtrechtDirección de correo verificada de umcutrecht.nl
Allan BradleyDept of Medicine, Cambridge University, UKDirección de correo verificada de cam.ac.uk
Ulrich Lehmann, Professor für Molekul...Medizinische Hochschule HannoverDirección de correo verificada de MH-Hannover.de
Jeroen de RidderFull professor University Medical Center UtrechtDirección de correo verificada de umcutrecht.nl
Reuven AgamiDirección de correo verificada de nki.nl
Annemieke de VriesNetherlands Forensic InstituteDirección de correo verificada de nfi.nl
Gerrit A Meijerprofessor of oncologic pathology, Netherlands Cancer Institute, University Medical Center UtrechtDirección de correo verificada de nki.nl
Daoud SieHuman Genetics, Amsterdam UMCDirección de correo verificada de amsterdamumc.nl

Seguir

Henne Holstege

Amsterdam UMC, Alzheimer Center, Clinical Genetics

Dirección de correo verificada de vumc.nl - Página principal

Molecular biology genetics clinical genetics aging alzheimer


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Alzheimer's disease P Scheltens, B De Strooper, M Kivipelto, H Holstege, G Chételat, ... The Lancet 397 (10284), 1577-1590, 2021	3004	2021
New insights into the genetic etiology of Alzheimer’s disease and related dementias C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ... Nature genetics 54 (4), 412-436, 2022	1364	2022
Activation of central melanocortin pathways by fenfluramine LK Heisler, MA Cowley, LH Tecott, W Fan, MJ Low, JL Smart, ... Science 297 (5581), 609-611, 2002	588	2002
Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer X Liu, H Holstege, H van der Gulden, M Treur-Mulder, J Zevenhoven, ... Proceedings of the National Academy of Sciences 104 (29), 12111-12116, 2007	535	2007
Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatin B Evers, R Drost, E Schut, M de Bruin, E van der Burg, PWB Derksen, ... Clinical Cancer Research 14 (12), 3916-3925, 2008	407	2008
A meta-analysis of genome-wide association studies identifies multiple longevity genes J Deelen, DS Evans, DE Arking, N Tesi, M Nygaard, X Liu, MK Wojczynski, ... Nature communications 10 (1), 3669, 2019	297	2019
BRD7 is a candidate tumour suppressor gene required for p53 function J Drost, F Mantovani, F Tocco, R Elkon, A Comel, H Holstege, ... Nature cell biology 12 (4), 380-389, 2010	240	2010
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ... Nature communications 12 (1), 3417, 2021	232	2021
High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer H Holstege, SA Joosse, CTM van Oostrom, PM Nederlof, A de Vries, ... Cancer research 69 (8), 3625-3633, 2009	216	2009
Somatic mutations found in the healthy blood compartment of a 115-yr-old woman demonstrate oligoclonal hematopoiesis H Holstege, W Pfeiffer, D Sie, M Hulsman, TJ Nicholas, CC Lee, T Ross, ... Genome research 24 (5), 733-742, 2014	205	2014
WISECONDOR: detection of fetal aberrations from shallow sequencing maternal plasma based on a within-sample comparison scheme R Straver, EA Sistermans, H Holstege, A Visser, CBM Oudejans, ... Nucleic acids research 42 (5), e31-e31, 2014	164	2014
Characterization of pathogenic SORL1 genetic variants for association with Alzheimer’s disease: a clinical interpretation strategy H Holstege, SJ Van Der Lee, M Hulsman, TH Wong, JGJ Van Rooij, ... European Journal of Human Genetics 25 (8), 973-981, 2017	124	2017
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the … SJ Van Der Lee, OJ Conway, I Jansen, MM Carrasquillo, L Kleineidam, ... Acta neuropathologica 138, 237-250, 2019	118	2019
Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer’s disease H Holstege, M Hulsman, C Charbonnier, B Grenier-Boley, O Quenez, ... Nature genetics 54 (12), 1786-1794, 2022	116	2022
Genome-wide significant risk factors for Alzheimer’s disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment A Lacour, A Espinosa, E Louwersheimer, S Heilmann, I Hernández, ... Molecular psychiatry 22 (1), 153-160, 2017	115	2017
Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases R Guerreiro, V Escott-Price, L Darwent, L Parkkinen, O Ansorge, ... Neurobiology of aging 38, 214. e7-214. e10, 2016	109	2016
A high-throughput pharmaceutical screen identifies compounds with specific toxicity against BRCA2-deficient tumors B Evers, E Schut, E van der Burg, TM Braumuller, DA Egan, H Holstege, ... Clinical Cancer Research 16 (1), 99-108, 2010	97	2010
Human and mouse oligonucleotide-based array CGH P van den IJssel, M Tijssen, SF Chin, P Eijk, B Carvalho, E Hopmans, ... Nucleic Acids Research 33 (22), e192-e192, 2005	94	2005
A whole-genome mouse BAC microarray with 1-Mb resolution for analysis of DNA copy number changes by array comparative genomic hybridization YJ Chung, J Jonkers, H Kitson, H Fiegler, S Humphray, C Scott, S Hunt, ... Genome research 14 (1), 188-196, 2004	93	2004
Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease A Lechel, H Holstege, Y Begus, A Schienke, K Kamino, U Lehmann, ... Gastroenterology 132 (4), 1465-1475, 2007	90	2007

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores